Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)

BACKGROUND: Anti-TNF therapy represented a landmark in medical treatment of ulcerative colitis (UC). There is lack of data on the efficacy and safety of these agents in Brazilian patients. The present study aimed to analyze rates of clinical and endoscopic remission comparatively, between adalimumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Sassaki, Ligia Yukie, Magro, Daniela Oliveira, Saad-Hossne, Rogerio, Baima, Julio Pinheiro, Flores, Cristina, Correia, Lucianna Motta, Celani, Lívia Medeiros Soares, De Abreu Ferrari, Maria De Lourdes, Zacharias, Patricia, Feitosa, Marley Ribeiro, Dos Santos, Carlos Henrique Marques, De Freitas Lins Neto, Manoel Alvaro, Quaresma, Abel Botelho, De Lima Junior, Sergio Figueiredo, De Vasconcelos, Graciana Bandeira Salgado, Cassol, Ornella Sari, Dos Santos Pinto, Arlene, Kurachi, Gustavo, Goncalves Filho, Francisco de Assis, Gasparini, Rodrigo Galhardi, Furlan, Thaísa Kowalski, Catapani, Wilson Roberto, Coy, Cláudio Saddy Rodrigues, De Souza Menegassi, Vivian, Colombo, Marilia Majeski, Fróes, Renata de Sá Brito, Teixeira, Fabio Vieira, Moraes, Antonio Carlos, Santana, Genoile Oliveira, Parente, José Miguel Luz, Vilela, Eduardo Garcia, Queiroz, Natália Sousa Freitas, Kotze, Paulo Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150299/
https://www.ncbi.nlm.nih.gov/pubmed/35644668
http://dx.doi.org/10.1186/s12876-022-02341-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150299/
https://www.ncbi.nlm.nih.gov/pubmed/35644668
http://dx.doi.org/10.1186/s12876-022-02341-7

Ejemplares similares